banner
Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell
Inquiry

Cat. No.: X23-06-YM250

Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell

Synonym: ST3GAL4

img
Product Size
20 μg; 100 μg; 200 μg
Price
Datasheet
MSDS
Properties
Description
Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell plays a key role in the synthesis of sialyl Lewis x glycan epitope that may serve as ligands for E- and P-selectins on activated endothelial cells in inflammatory responses.
Molecular Weight
39-41 kDa
Source
Mouse myeloma cell
Form
Solution
Purity
>95%, determined by SDS-PAGE.
Applications
Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell is useful for the investigation of renal carcinoma.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0